Close

Analyst Ratings for Eidos Therapeutics (EIDX) [Neutrals]

All Latest Ratings for EIDX

EIDX Rating Summary

  |   Expand Research on EIDX
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 1 / 10   Percentile Rank: 7%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
11/18/2020 BTIG Thomas Shrader Downgrade Neutral
(Buy)		 N/A
(N/A)		 81.21
(122.21)		 50.49% Details
10/7/2020 Citi
» Updated 12/29/2020		 Joel Beatty Downgrade Neutral
(Buy)		 129.00
(73.26)		 73.51
(122.21)		 66.25% Details